These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7755512)

  • 1. Functionally inactive S. aureus alpha-toxin containing a single amino acid substitution: potential usefulness as a vaccine.
    Bhakdi S; Jursch R; Bröker M; Ronneberger H; Hungerer KD
    Behring Inst Mitt; 1994 Dec; (95):80-4. PubMed ID: 7755512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model.
    Menzies BE; Kernodle DS
    Infect Immun; 1996 May; 64(5):1839-41. PubMed ID: 8613399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
    Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
    Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.
    Oscherwitz J; Cease KB
    PLoS One; 2015; 10(1):e0116882. PubMed ID: 25635901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effects of active immunization against alpha hemolysin of Staphylococcus aureus].
    Wleklinski CG; Neubüser U; Ronneberger H; Hungerer KD; Schaeg W; Blobel H
    Zentralbl Veterinarmed B; 1982 Sep; 29(8):596-603. PubMed ID: 7180248
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adjuvants on the immune response of staphylococcal alpha toxin and capsular polysaccharide (CPS) in rabbit.
    Han HR; Park HM
    J Vet Med Sci; 2000 Mar; 62(3):237-41. PubMed ID: 10770593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo mapping of a protective linear neutralizing epitope at the N-terminus of alpha hemolysin from Staphylococcus aureus.
    Oscherwitz J; Muñoz-Planillo R; Yu F; Núñez G; Cease KB
    Mol Immunol; 2014 Jul; 60(1):62-71. PubMed ID: 24769493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of new enzyme-linked immunosorbent assay based on a supernatant containing Staphylococcus aureus alpha-toxin produced by Bacillus subtilis.
    Egnell P; Christensson B; Möllby R; Flock JI
    J Clin Microbiol; 1993 Nov; 31(11):3036-9. PubMed ID: 8263193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP; Thompson CD; Aman MJ; Lee JC
    Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
    Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ
    PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent Evolution of Neutralizing Antibodies to Staphylococcus aureus γ-Hemolysin C That Recognize an Immunodominant Primary Sequence-Dependent B-Cell Epitope.
    Hernandez DN; Tam K; Shopsin B; Radke EE; Law K; Cardozo T; Torres VJ; Silverman GJ
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546616
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia.
    Sharma-Kuinkel BK; Wu Y; Tabor DE; Mok H; Sellman BR; Jenkins A; Yu L; Jafri HS; Rude TH; Ruffin F; Schell WA; Park LP; Yan Q; Thaden JT; Messina JA; Fowler VG; Esser MT
    J Clin Microbiol; 2015 Jan; 53(1):227-36. PubMed ID: 25392350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
    Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
    J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperproduction of alpha-toxin by Staphylococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins.
    Bayer AS; Ramos MD; Menzies BE; Yeaman MR; Shen AJ; Cheung AL
    Infect Immun; 1997 Nov; 65(11):4652-60. PubMed ID: 9353046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
    J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Bonifacius A; Goldmann O; Floess S; Holtfreter S; Robert PA; Nordengrün M; Kruse F; Lochner M; Falk CS; Schmitz I; Bröker BM; Medina E; Huehn J
    Front Immunol; 2020; 11():1579. PubMed ID: 32849537
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin.
    Yanagisawa C; Hanaki H; Natae T; Sunakawa K
    J Infect Chemother; 2007 Dec; 13(6):368-72. PubMed ID: 18095084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.